The study covers a detailed analysis segmented by key business segments i.e. by type (Sulfadimethoxine, Sulfaguanidine, Furazolidone, Trimethoprim/Sulfonamide and Others) , by application (Poultry, Dog, Fish, Cat, Cattle and Others) and major geographies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Coccidiosis Treatment market throughout the predicted period.
What is Coccidiosis Treatment?
Coccidiosis is caused by Eimeria, which are single-celled parasites (protozoa) that have a simple life cycle in the gut. Anticoccidial medications are critical in preventing and treating coccidiosis. Weight loss, mild intermittent to severe diarrhea, feces containing blood or mucus, dehydration, and decreased breeding are all signs of coccidiosis, one of the most common parasite illnesses of farmed animals.
The competition is expected to become even more intense in the years to come due to entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the markets competitive landscape and offers information on the products offered by various leading companies. Additionally, this Coccidiosis Treatment market analysis report suggests strategies Players can follow and recommends key areas they should focus on, in order to take maximum benefits of growth opportunities.
The report offers several leading Players, including:
- Elanco Animal Health (United States)
- Huvepharma (United States)
- Phibro Animal Health (United States)
- US Biologic (United States)
- Ceva Animal Health (France)
- Zoetis (United States)
- Impextraco (Belgium)
- Kemin Industries (United States)
- Merck Animal Health (United States)
- Virbac SA (France)
On 04 June 2021, the US Department of Agriculture, Agriculture Research Service, and US Biologic Inc. has developed an Oral Antibiotic option for the treatment of chicken coccidiosis. The newly developed oral solution comes in the form of a probiotic powder that can be blended into existing feed procedures and provided to birds throughout their lives without needing any additional stages or components. This oral approach will significantly minimize the clinical impact of coccidiosis, reduce disease transmission, and enhance poultry gut health. This indicates that birds given NK-2 have a healthier gut and are less prone to illness. The technique has been patented by the USDA-ARS and US Biologic, and US Biologic has signed an exclusive global commercialization agreement with the objective of developing and licensing it for industrial usage.
Adoption of Latest Technologies and New Development of Drug for Treatment
- Growing Resistance of the Pathogen, Expensive Treatment and Prevention Will Constrain the Coccidiosis Treatment Market
Increasing Concern Towards Animal Health and Maintaining Healthier Diet Will Propel the Coccidiosis Treatment Market and Increasing Number of Veterinary Hospitals and Improvement in Drug Quality will grow the Coccidiosis Treatment Market
Key highlights of the Global Coccidiosis Treatment market Study:
CAGR of the market during the forecast period 2020-2026
In-depth information on growth factors that will accelerate the Coccidiosis Treatment market in next few years.
Detailed Insights on futuristic trends and changing consumer behaviour
Forecast of the Global Coccidiosis Treatment market size and its contribution to the parent market by type, application and by country.
A broad view of customer demand
Uncover markets competitive landscape and in-depth information on various Players
Comprehensive information about factors that will challenge the growth of Coccidiosis Treatment Players
Transformation and Important Trigegrs:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
A tipping point in globalization
A major slowdown in Western economies
Significant shifts in technology and cost structure
The challenges of regulatory compliance
New forms of competition developing
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Coccidiosis Treatment market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Coccidiosis Treatment market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes Coccidiosis Treatment Manufactures, Coccidiosis Treatment Distributors and Suppliers, Research and Development Institutes, Upstream and Downstream Buyers, Financial Institutes and Investors, Regulatory Bodies and Others.
This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.
Frequently Asked Questions (FAQ):1. Where the Coccidiosis Treatment industry is heading?
Coccidiosis Treatment Market is heading robustly to achieve new growth cycle.2. Is Coccidiosis Treatment market is changing from growth to value?
The Concentration Rate of Global Coccidiosis Treatment market is dominated by United States Players to generate healthy valuation by 2026. 3. Who are the key players profiled in the Coccidiosis Treatment Market?
Companies that are profiled in Global Coccidiosis Treatment Market are Elanco Animal Health (United States), Huvepharma (United States), Phibro Animal Health (United States), US Biologic (United States), Ceva Animal Health (France), Zoetis (United States), Impextraco (Belgium), Kemin Industries (United States), Merck Animal Health (United States) and Virbac SA (France) etc.